Posted and filed under Fraud, Healthcare.

Fraud Spotlight: Compounding Pharmacy Fraud

Recently, the State of New Jersey, Division of Consumer Affairs (the department that administers, among other things, the Prescription Monitoring Program [PMP]), reclassified a drug known as Gabapentin.  In reclassifying the drug, it is now considered a scheduled drug in New Jersey, and must now be part of the PMP reporting. For those that do not…

Read the full article